TY  - JOUR
AU  - Filella, Xavier
AU  - Albaladejo, María Dolores
AU  - Allué, Juan Antonio
AU  - Castaño, Miguel Angel
AU  - Morell-Garcia, Daniel
AU  - Ruiz, Maria Àngels
AU  - Santamaría, María
AU  - Torrejón, María José
AU  - Giménez, Nuria
PY  - 2019
DO  - 10.1515/cclm-2018-1252
UR  - http://hdl.handle.net/10668/14004
T2  - Clinical chemistry and laboratory medicine
AB  - Background Prostate-specific antigen (PSA) remains as the most used biomarker in the detection of early prostate cancer (PCa). Clinical practice guidelines (CPGs) are produced to facilitate incorporation of evidence into clinical practice. This is...
LA  - en
KW  - clinical practice guidelines
KW  - prostate cancer
KW  - prostate-specific antigen (PSA)
KW  - screening
KW  - Clinical Laboratory Techniques
KW  - Early Detection of Cancer
KW  - Humans
KW  - Male
KW  - Mass Screening
KW  - Prostate-Specific Antigen
KW  - Prostatic Neoplasms
TI  - Prostate cancer screening: guidelines review and laboratory issues.
TY  - research article
VL  - 57
ER  -